StockData
Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc. (ALGS) dividend history

ALGSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/3043% below fair value
$1.66−0.44 (-20.95%)

Close on Nov 16, 2026Market cap $20.73MP/E –Yield –

Dividends

Aligos Therapeutics has not reported a dividend

No dividend per share appears in Aligos Therapeutics's annual filings since fiscal 2018.

See a number that looks wrong?